20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
The July 15 launch date for the new Component 2 EEO-1 Compensation Data Filing System (Component 2 E...
Read More >
• Following the financial crisis, nonbank lenders looking to carve out new, profitable niches—espe...
Read More >
Seyfarth Synopsis: The U.S. Chemical Safety and Hazard Investigation Board (CSB) has proposed new ac...
Read More >
The government just sent a stern reminder to all employers, especially those involved in providing h...
Read More >
If you watch the news, you may have heard that the requirement known as the “individual mandate” u...
Read More >
The FTI Journal continues its look at opportunities for private equity in distressed M&A given the p...
Read More >